50 EUR
3
6.38%
Last update Dec 12, 12:51 PM CET
Market closed
Day range
48
50
Previous close
47
Open
49
Access this stock data via API
Subscribe
Crispr Therapeutics AG
50.00
3
6.38%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024
Total reported revenue 29.8M
Cost of revenue 93.9M
Gross profit -64.1M
Operating expense
Research & development 273.1M
Selling general and admin 62.2M
Other operating expenses -2.0M
Operating income -397.4M
Non operating interest income
Income
Expense
Other income expense 88.5M
Pretax income -308.9M
Tax provision 3.1M
Net income -312.0M
Basic EPS -4.3
Diluted EPS -4.3
Basic average shares 71.9M
Diluted average shares 71.9M
EBITDA -381.0M
Net income from continuing op. -312.0M
Minority interests
Preferred stock dividends
Access /income_statement data via our API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 5 hours 35 minutes

02:24
00:00
08:00
22:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 22:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).